Northland Capital Markets Starts Stereotaxis (STXS) at Outperform

Northland Capital Markets analyst Jason Wittes initiates coverage on Stereotaxis (OTC: STXS) with a Outperform rating and a price target of $9.50.

The analyst comments "The company offers a unique robotic magnetic navigation system, with a primary focus on arrhythmias. New management has taken a disciplined approach, bringing the company to break even, while block and tackling to widen the opportunity and claim a bigger piece of the reimbursement pie, setting the company up for significant growth in the coming years and establishing immense strategic value."

For an analyst ratings summary and ratings history on Stereotaxis click here. For more ratings news on Stereotaxis click here.

Shares of Stereotaxis closed at $3.17 yesterday.

You May Also Be Interested In

• Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
• Morgan Stanley Starts Rio Tinto (RIO) at Underweight
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics